REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P953. A total of 4 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,202,336 | -65.3% | 21,600 | -69.1% | 0.01% | -69.6% |
| Q1 2023 | $6,346,216 | +1195.0% | 69,800 | +441.1% | 0.02% | +2200.0% |
| Q4 2022 | $490,071 | -77.8% | 12,900 | -85.3% | 0.00% | -75.0% |
| Q3 2022 | $2,204,000 | +225.1% | 87,700 | +293.3% | 0.00% | +300.0% |
| Q2 2022 | $678,000 | -37.3% | 22,300 | -32.4% | 0.00% | 0.0% |
| Q1 2022 | $1,081,000 | +141.3% | 33,000 | +94.1% | 0.00% | – |
| Q4 2021 | $448,000 | -88.4% | 17,000 | -55.7% | 0.00% | -100.0% |
| Q3 2021 | $3,863,000 | +103.6% | 38,400 | +186.6% | 0.00% | +100.0% |
| Q2 2021 | $1,897,000 | +134.8% | 13,400 | +65.4% | 0.00% | +100.0% |
| Q1 2021 | $808,000 | +3132.0% | 8,100 | +3950.0% | 0.00% | – |
| Q4 2020 | $25,000 | -92.9% | 200 | -94.4% | 0.00% | -100.0% |
| Q3 2020 | $351,000 | -60.5% | 3,600 | -36.8% | 0.00% | -75.0% |
| Q2 2020 | $889,000 | -69.4% | 5,700 | -71.6% | 0.00% | -83.3% |
| Q1 2020 | $2,901,000 | +208.6% | 20,100 | +337.0% | 0.02% | +300.0% |
| Q4 2019 | $940,000 | +1075.0% | 4,600 | +360.0% | 0.01% | +500.0% |
| Q3 2019 | $80,000 | -29.2% | 1,000 | -16.7% | 0.00% | 0.0% |
| Q2 2019 | $113,000 | +9.7% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $103,000 | +1187.5% | 1,200 | +1100.0% | 0.00% | – |
| Q3 2018 | $8,000 | +166.7% | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | -25.0% | 100 | -50.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 171 | $2,114,000 | 0.08% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING LLC | 200 | $25,000 | 0.00% |
| SIMPLEX TRADING, LLC | 5 | $61,000 | 0.00% |